Table 1 Patient characteristics by cured and not cured
All (n=96) | Cured (n=46) | Not cured (n=50) | P-value (cured vs. not cured) | |
|---|---|---|---|---|
Age at surgery, years | 51±11 | 47±12 | 55±10 | 0.0009 |
Male, n (%) | 40 (41.7) | 13 (28.3) | 27 (54.0) | 0.0106 |
BMI, kg m−2 | 23.3±3.5 | 21.8±3.4 | 24.6±3.0 | <0.0001 |
Complication of DM, n (%) | 4 (4.2) | 2 (4.4) | 2 (4.0) | 0.9321 |
Complication of DL, n (%) | 18 (18.8) | 5 (10.9) | 13 (26.0) | 0.0587 |
Past history of CVD, n (%) | 5 (5.2) | 2 (4.4) | 3 (6.0) | 0.7159 |
Smoking, n (%) | 32 (33.7) | 12 (26.1) | 20 (40.8) | 0.129 |
Alcohol, n (%) | 32 (33.7) | 15 (32.6) | 17 (34.7) | 0.8298 |
Family history of HTN, n (%) | 67 (69.8) | 33 (71.7) | 34 (68.0) | 0.6902 |
Preoperative systolic BP, mm Hg | 140±17 | 138±13 | 142±21 | 0.3419 |
Preoperative diastolic BP, mm Hg | 85±12 | 84±11 | 86±13 | 0.5771 |
Number of antihypertensive medications | 1.3±0.9 | 1.1±0.7 | 1.5±1.0 | 0.0338 |
K+ supplementation, n (%) | 47 (49.0) | 25 (54.4) | 22 (44.0) | 0.311 |
MRB medication, n (%) | 65 (67.7) | 29 (63.0) | 36 (72.0) | 0.3485 |
K+, mEq l−1 | 3.2±0.5 | 3.2±0.4 | 3.2±0.6 | 0.5027 |
UA, mg dl−1 | 4.9±1.4 | 4.4±1.1 | 5.5±1.4 | <0.0001 |
eGFR, ml min−1 per 1.73 m2 | 78.2±20.8 | 81.7±16.0 | 75.0±24.1 | 0.1172 |
PAC, pg ml−1 | 362±269 | 338±179 | 384±332 | 0.3999 |
PRA, ng ml−1 h−1 | 0.3±0.4 | 0.3±0.2 | 0.3±0.5 | 0.3729 |
ARR | 2545±4331 | 2727.3±5522.6 | 2374.7±2843.2 | 0.6939 |
Urinary aldosterone excretion, μg per day | 24.4±15.2 | 25±16 | 23±14 | 0.6102 |
Urinary Na+/K+ excretion | 3.0±1.5 | 2.9±1.6 | 3.1±1.3 | 0.4891 |
Tumor diameter, mm | 14.6±5.4 | 14.3±4.6 | 15.0±6.2 | 0.5019 |
Pathologic diagnosis | ||||
Cortical adenoma, n (%) | 76 (79) | 37 (80.4) | 38 (79.8) | 0.8784 |
Nodular hyperplasia, n (%) | 4 (4) | 0 (0) | 4 (8.3) | 0.0454 |
Cortical adenoma + hyperplasia, n (%) | 16 (17) | 9 (19.6) | 6 (12.5) | 0.3498 |
Postoperative systolic BP, mm Hg | 125±12 | 122±13 | 127±11 | 0.0375 |
Postoperative diastolic BP, mm Hg | 79±8 | 78±9 | 79±8 | 0.7381 |
Postoperative antihypertensive medications | 0.7±0.8 | 0.0±0.0 | 1.3±0.6 | <0.0001 |